Appeal No. 1997-0094
Application No. 08/188,232
In reaching our decision in this appeal we have given careful consideration to the
appellant's specification and claims and to the respective positions articulated by the
appellant and the examiner. We make reference to the examiner's answer (Paper No. 17,
mailed May 14, 1996) and to the examiner's supplemental answer (Paper No. 20, mailed
October 15, 1996) for the examiner's reasoning in support of the rejection and to the
appellant's brief (Paper No. 16, filed December 4, 1995), to the appellant's reply brief
(Paper No. 19, filed July 12, 1996) and to the appellant's second reply brief (Paper No. 21,
filed December 16, 1996) for the appellant's arguments thereagainst.
BACKGROUND
Prothymosin ", a native thymic polypeptide isolated from thymosin fraction 5, is the
precursor from which a number of biologically active peptides, including thymosin " and
1
two related peptides, des-(25-28)-thymosin " and thymosin " , are derived. Thymosin1 11
" is defined by the first 28 amino acid residues of the N-terminal of prothymosin "; des-
1
(25-28)-thymosin " by the first 24 amino acid residues; and, thymosin " by the1 11
sequence of thymosin " plus seven additional residues at the COOH terminus. See
1
Haritos, p. 1008, c. 1 and Zatz, Table I.
- 4 -
Page: Previous 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007